About Lupitas Pharmaceuticals
Lupitas Pharmaceuticals was a Healthcare company based in Vadodara (India) founded in 2014. It serves as a CDMO specializing in the manufacturing of solid drug formulations. It operates on a B2B model. The company has 9 employees. Its Indian entity Lupitas Pharmaceuticals Private Limited reported revenue of ₹1.03 Cr. The company is recorded as dissolved. Its focus areas include Pharmaceuticals, Manufacturing and CDMO Services. Its competitors include Inventia Healthcare, Zim Labs and Halewood Laboratories; 2 of its 3 listed competitors have raised funding.
Company details
Lupitas Pharmaceuticals, based in Vadodara, focuses on providing healthcare solutions, producing pharmaceutical products, producing manufactured goods, and cdmo services. Serves as a CDMO specializing in the manufacturing of solid drug formulations. The company prioritizes operational excellence, innovation, and customer-centric approaches for success.
- Headquarters Vadodara, India
- Employees 9
- SectorsHealthcare
- Website lupitaspharmaceuticals.com
- Legal Name Lupitas Pharmaceuticals Private Limited
- Date of Incorporation 31 Mar, 2014
- Jurisdiction Surat, Gujarat, India
- Annual Revenue₹1.03 Cr
FY 2026 · +12% YoY
- Net Profit₹97,776
FY 2026 · 1% margin
- EBITDA₹1.2 Lakh
FY 2026 · 1% margin
- Employee Count9
Associated legal entities of Lupitas Pharmaceuticals
Lupitas Pharmaceuticals operates through Lupitas Pharmaceuticals Private Limited (active). Its filings, financials, charges and directors are on the company page.
| Legal entity | Status | Incorporated | Registered in | Revenue (FY 2026) | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| Lupitas Pharmaceuticals Private Limited CIN U24100GJ2014PTC079490 | Active | 31 Mar 2014 | Surat, Gujarat | ₹1.0 Cr | 9 | 6 | View details |
Board of directors of Lupitas Pharmaceuticals Private Limited (Lupitas Pharmaceuticals)
Lupitas Pharmaceuticals Private Limited is the primary company behind Lupitas Pharmaceuticals. The board of Lupitas Pharmaceuticals Private Limited currently have 6 directors; the longest-serving is Ghanshyam Parsottambhai Laheri, appointed in 2014. 23 earlier directors have ceased.
| Director | Designation | Appointed | Tenure | Entity |
|---|---|---|---|---|
| Ghanshyam Parsottambhai Laheri DIN 06850023 | Director | 31 Mar 2014 | 12 yrs 7 mo | Lupitas Pharmaceuticals Private Limited |
| Hetalben Dipakbhai Bhadiyadara DIN 07191543 | Director | 12 Jun 2015 | 11 yrs 5 mo | Lupitas Pharmaceuticals Private Limited |
| Kishorkumar Maganbhai Kachhadiya DIN 07191562 | Director | 12 Jun 2015 | 11 yrs 5 mo | Lupitas Pharmaceuticals Private Limited |
| Ashish Rameshchandra Pandya DIN 07278199 | Director | 18 Sep 2015 | 11 yrs 1 mo | Lupitas Pharmaceuticals Private Limited |
| Pareshkumar Ramjibhai Dhameliya DIN 08265961 | Director | 04 Aug 2021 | 5 yrs 3 mo | Lupitas Pharmaceuticals Private Limited |
| Bhanuben Pravinbhai Vekariya DIN 11716098 | Director | 19 May 2026 | 5 mo | Lupitas Pharmaceuticals Private Limited |
Financials of Lupitas Pharmaceuticals
Figures of Lupitas Pharmaceuticals Private Limited, the primary company behind Lupitas Pharmaceuticals, for FY 2026. Revenue was ₹1.03 Cr (+12% year on year). Net profit was ₹97,776 (1% margin). EBITDA was ₹1.2 Lakh (1% margin). Revenue has grown at a compounded annual rate of +1% over three years and +9% over five years.
- ₹1.03 CrRevenue · FY 2026 · +12% YoY
- ₹97,776Net profit · 1% margin
- ₹1.2 LakhEBITDA · 1% margin
- ₹7 LakhPaid-up capital
- 9Employees (provident fund records)
- +1%Revenue CAGR, 3 years
- +9%Revenue CAGR, 5 years
Balance sheet, profit and loss, cash flow and ratios of Lupitas Pharmaceuticals Private Limited are on its company page.
Detailed financial statements for Lupitas Pharmaceuticals
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Competitors of Lupitas Pharmaceuticals
Lupitas Pharmaceuticals has 3 listed competitors in our database, 2 of them funded. They include Inventia Healthcare, Zim Labs and Halewood Laboratories.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| inventiahealthcare.com | 1985 | Mumbai, India | $42.49M | 980 | Oral solid drug delivery systems are manufactured and developed. | |
| zimlab.in | 1989 | Nagpur, India | $8.2M | 598 | Solid and semisolid dosage forms are developed and manufactured. | |
| halewoodlabs.com | 1984 | Ahmedabad, India | 348 | Provides contract manufacturing services for food, pharmaceuticals, and related products globally. |
Detailed competitors of Lupitas Pharmaceuticals
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Lupitas Pharmaceuticals
Lupitas Pharmaceuticals was founded in 2014.
Lupitas Pharmaceuticals is headquartered in Vadodara, India. It is registered at Vadodara, Gujarat, India.
Lupitas Pharmaceuticals has 9 employees.
The primary company behind Lupitas Pharmaceuticals, Lupitas Pharmaceuticals Private Limited, reported revenue of ₹1.03 Cr for FY 2026, up 12% year on year.
Lupitas Pharmaceuticals, based in Vadodara, focuses on providing healthcare solutions, producing pharmaceutical products, producing manufactured goods, and cdmo services. Serves as a CDMO specializing in the manufacturing of solid drug formulations. The company prioritizes operational excellence, innovation, and customer-centric approaches for success.
Lupitas Pharmaceuticals's top competitors include Inventia Healthcare, Zim Labs and Halewood Laboratories.
Lupitas Pharmaceuticals operates through Lupitas Pharmaceuticals Private Limited.
The legal entities of Lupitas Pharmaceuticals currently have 6 directors, including Ghanshyam Parsottambhai Laheri, Hetalben Dipakbhai Bhadiyadara, Kishorkumar Maganbhai Kachhadiya and others.